Cookson Peirce & CO Inc Bristol Myers Squibb CO Transaction History

Cookson Peirce & CO Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 01, 2023	SELL	$63.71 - $70.74 $7.09 Million - $7.87 Million	-111,244 Reduced 90.73%	11,360 $726,000
Q1 2023 May 03, 2023	BUY	$65.71 - $74.53 $75,369 - $85,485	1,147 Added 0.94%	122,604 $8.5 Million
Q4 2022 Jan 31, 2023	BUY	$68.48 - $81.09 $6.96 Million - $8.24 Million	101,616 Added 512.15%	121,457 $8.74 Million
Q3 2022 Nov 08, 2022	BUY	$0.13 - $76.84 $173 - $102,504	1,334 Added 7.21%	19,841 $1.41 Million
Q2 2022 Jul 20, 2022	BUY	$72.62 - $79.98 $852,776 - $939,205	11,743 Added 173.61%	18,507 $1.43 Million
Q1 2022 May 03, 2022	BUY	$61.48 - $73.72 $415,850 - $498,642	6,764 New	6,764 $493,000

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Cookson Peirce & CO Inc, based on Form 13F filings with the SEC.

Stay updated on Cookson Peirce & CO Inc with notifications on news.